[Implantable cardioverter defibrillators in pediatric patients: results in a series of 33 cases].
Implantable defibrillator is the recognized treatment of sudden cardiac death. Miniaturization of the devices allows implantation in children.


METHODS
This multicentric retrospective study analyzed data of 33 children aged 18 years and less who were implanted from 1990 to 2005.


RESULTS
Age of patients are 10 to 18 years, 20 patients were implanted after a resuscitation of sudden death, 10 after a syncope, 2 after a ventricular tachycardia and 1 in a prophylactic way. Tachycardias on primary electrical disease are most frequent (46%). Hypertrophic cardiomyopathy accounts for 22%, DAVD for 14%, congenital cardiopathies for 12%. Seventeen patients received appropriate shocks and 14 patients had inappropriate shocks. There were two unexplained deaths. Five leads fractures and two device infections were noted.


CONCLUSIONS
Implantable defibrillator is an effective treatment for children high-risk of sudden death. Occurrence of inappropriate shocks due to sinusal tachycardia, infections and leads fractures are frequent.
Tisserant
A
A
Service de cardiologie infantile, CHU de Nancy, hôpital d'Enfants, Vandoeuvre-les-Nancy.
Sadoul
N
N
Kouakam
C
C
Kacet
S
S
Rey
C
C
Chauvin
M
M
Lévy
J
J
Mabo
P
P
Marçon
F
F
D000293:Adolescent; D002312:Cardiomyopathy, Hypertrophic / Q000628:therapy; D002648:Child; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D005260:Female; D005500:Follow-Up Studies; D005602:France; D006330:Heart Defects, Congenital / Q000628:therapy; D006801:Humans; D008297:Male; D008499:Medical Records; D012189:Retrospective Studies; D017180:Tachycardia, Ventricular / Q000628:therapy; D016896:Treatment Outcome